1. Home
  2. SUNB vs ROIV Comparison

SUNB vs ROIV Comparison

Compare SUNB & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunbelt Rentals Holdings Inc. Common Stock

SUNB

Sunbelt Rentals Holdings Inc. Common Stock

N/A

Current Price

$81.45

Market Cap

31.2B

ML Signal

N/A

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$41.33

Market Cap

28.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SUNB
ROIV
Founded
1947
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.2B
28.7B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
SUNB
ROIV
Price
$81.45
$41.33
Analyst Decision
Buy
Strong Buy
Analyst Count
16
13
Target Price
★ $88.97
$49.91
AVG Volume (30 Days)
3.2M
★ 7.2M
Earning Date
12-23-2026
11-09-2026
Dividend Yield
★ 1.47%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.07
N/A
Revenue
★ $11,154,000,000.00
$8,260,000.00
Revenue This Year
$7.93
$562.28
Revenue Next Year
$7.43
$734.15
P/E Ratio
$76.78
★ N/A
Revenue Growth
★ 3.36
N/A
52 Week Low
$61.03
$19.96
52 Week High
$86.68
$42.50

Technical Indicators

Market Signals
Indicator
SUNB
ROIV
Relative Strength Index (RSI) 55.79 66.22
Support Level $71.10 $33.11
Resistance Level $85.79 $42.50
Average True Range (ATR) 3.02 1.52
MACD -0.27 0.53
Stochastic Oscillator 59.36 94.46

Price Performance

Historical Comparison
SUNB
ROIV

About SUNB Sunbelt Rentals Holdings Inc. Common Stock

Sunbelt Rentals (formerly UK-based Ashtead Group) is the number two equipment rental company in the US (11% market share), with a smaller presence in Canada and the UK. Sunbelt operates a rental fleet of just over $20 billion across a network of 1,200 stores in the US, nearly 135 stores in Canada, and and 190 stores in the UK. The company has experienced rapid growth over the past decade as its customers increasingly turn to rental versus owning equipment outright. The general tool business has been augmented by the Specialty Rental business, which has grown to 30% of the mix. Revenue is now greater than 50% nonconstruction, with the remainder focused more directly on commercial construction.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: